Carolyn Tallon

Years Active: 2022-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Carolyn Tallon, Benjamin J Bell, Medhinee M Malvankar, Pragney Deme, Carlos Nogueras-Ortiz, Erden Eren, Ajit G Thomas, Kristen R Hollinger, Arindom Pal, Maja Mustapic, Meixiang Huang, Kaleem Coleman, Tawnjerae R Joe, Rana Rais, Norman J Haughey, Dimitrios Kapogiannis, Barbara S Slusher
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer's disease. Research square (2023)
Rana Rais, Kathryn M Lemberg, Lukáš Tenora, Matthew L Arwood, Arindom Pal, Jesse Alt, Ying Wu, Jenny Lam, Joanna Marie H Aguilar, Liang Zhao, Diane E Peters, Carolyn Tallon, Rajeev Pandey, Ajit G Thomas, Ranjeet P Dash, Tanguy Y Seiwert, Pavel Majer, Robert D Leone, Jonathan D Powell, Barbara S Slusher
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug. Science advances 8 (46) (2022)
Carolyn Tallon, Benjamin J Bell, Anjali Sharma, Arindom Pal, Medhinee M Malvankar, Ajit G Thomas, Seung-Wan Yoo, Kristen R Hollinger, Kaleem Coleman, Elizabeth L Wilkinson, Sujatha Kannan, Norman J Haughey, Rangaramanujam M Kannan, Rana Rais, Barbara S Slusher
Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice. Pharmaceutics 14 (10) (2022)

Carolyn Tallon.css-eqlu8i{font-size:small;padding-left:4px;}